The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects

Completed · Phase 1

Conditions studied: Healthy

In brief

The purpose of this study is to assess the effect of omeprazole on the pharmacokinetics of dasatinib in healthy subjects and to assess the safety and tolerability of a single dose of dasatinib before and after 5 days of dosing with omeprazole in healthy subjects

Key facts

Study ID

NCT00655746

Run by

Bristol-Myers Squibb

People needed

14

Starts

2008-04-01

Expected to finish

2008-05-01

Last updated by the study team

2009-12-15

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy subjects as determined by medical history, physical examination, ECGs, and clinical laboratory determinations

You may not qualify if…

• Women who are pregnant or breastfeeding
• Prior exposure to dasatinib

Where it is running

• Bristol-Myers Squibb Clinical Pharmacology Unit — Hamilton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.